Edition:
United States

Magellan Health Inc (MGLN.O)

MGLN.O on Nasdaq

71.45USD
24 Apr 2017
Change (% chg)

$0.75 (+1.06%)
Prev Close
$70.70
Open
$71.70
Day's High
$71.70
Day's Low
$70.85
Volume
160,477
Avg. Vol
151,836
52-wk High
$84.71
52-wk Low
$49.50

Select another date:

Wed, Apr 12 2017

BRIEF-Magellan health CEO Barry Smith's FY 2016 total compensation was $7.45 mln

* CEO Barry Smith's FY 2016 total compensation was $7.45 million versus $6.2 million - sec filing Source text : http://bit.ly/2p5SB75 Further company coverage:

BRIEF-Magellan Health reports Q4 earnings per share $1.50

* Magellan Health reports fourth quarter 2016 and full year financial results

BRIEF-Magellan Health enters into credit agreement that provides for a $200 mln delayed draw term loan

* Magellan Health Inc - On January 10, 2017 co entered into a credit agreement that provides for a $200.0 million delayed draw term loan - SEC filing

BRIEF-KNF allows for re-materialization of Magellan's shares

Nov 23 Polish Financial Supervision Authority (KNF):

BRIEF-Magellan Health provides 2017 financial guidance

* Magellan Health Inc - expects cash flow from operations in range of $186 million to $220 million in 2017

BRIEF-Magellan Health to acquire Veridicus Holdings

* Closing of transaction is expected before end of year and is not subject to Hart-Scott-Rodino Ac

BRIEF-Magellan Q3 net profit down at 9.9 mln zlotys yoy

* Q3 revenue 40.0 million zlotys ($9.9 million) versus 40.6 million zlotys year ago

BRIEF-G. Scott Mackenzie appointed to Magellan Health board of directors

* G. Scott Mackenzie appointed to Magellan Health board of directors

Select another date:

More From Around the Web